www.novabooks.info

International Technical Bookstore.

BP 2005 in 6 Volumens

Pharmaceutical Book → WWW.NOVABOOKS.INFO

THE MERCK INDEX 15 edition

Pharmaceutical Books.

NIIF 2014 in 2 Volumes IFRS

Accounting Book.

Bookstore

Technical Bookstore.

domingo, 1 de marzo de 2015

Drug Facts and Comparisons 2015


Drug Facts and Comparisons 2015
Author: Facts & Comparisons
Publisher: Lippincott Williams & Wilkins
Published: 2014
Format: Hardback, 1 volume + 1 CD-ROM
Pages: 3,890 pp.
Product Dimensions: 28.00 cm. x 22.50 cm.
ISBN: 9781574393606

Drug Facts and Comparisons provides up-to-date information on over 22,000 Rx and 6,000 OTC products grouped by therapeutic category for ease of comparison.Drug Facts and Comparisonshelps answer questions about actions, indications and contraindications, warnings and precautions; drug interactions, adverse reactions, administration and dosage, pregnancy and lactation, and patient information. Comparisons include drug to drug, dosage forms, and name brands to name brands and generics. Biologicals and antiparasitic drugs, IV solutions, and therapeutic and diagnostic ophthalmic preparations are also included.This hardbound edition includes theDrug Identifier 2015CD-ROM, the premier tool for drug identification. Search more than 10,000 color images in seconds by drug name, imprint, NDC, color, shape, manufacturer, coating, scoring, clarity, and flavor.

Includes:
§  Over 22,000 Rx and 6,000 OTC products, including generic and trade names
§  More than 3,000 unique charts and tables
§  Appendix of treatment guidelines
§  Extensive manufacturer/distributor list

Benefits:
§  Increases productivity by providing quick access
§  Supports therapeutic decision making and improves patient outcomes
§  Saves time with easy-to-read charts and comparative tables

Purpose: The book includes drug monographs for each drug and compares all the medications within each class. Chapters are organized based on therapeutic uses for each medication. This reference is key for comparing similar drugs in terms of therapy, yet it allows for differentiation based on an individual patient's medical history. It is designed to allow readers to compare and contrast medications and reach a conclusion about which drug should be used in a individual patient cases. It is inclusive, comprehensive, and up to date. This allows for timely reference and provides current and relevant data.
Audience: All healthcare practitioners, including pharmacists, physicians, and nurse practitioners, will find this reference helpful in their daily prescribing practices. In situations where formularies are of relevance, this reference could be used to compare agents on the market to make appropriate and informed therapeutic decisions.
Features: The 13 chapters are organized by therapeutic class allowing for comparison between each agent. Each chapter is then organized into subgroups via the mini-index at the beginning of each chapter. The index at the end of the book is also easy to use, and it includes disease states and brand/generic drug names. The drug information is presented in a package-insert manner, including all published monograph information. Charts within the different therapeutic areas provide more concise comparisons between different drugs. Off-label recommendations are presented with ratings of therapeutic evidence. Although this reference is great for comparison, it may not be ideal for searching for general drug information responses. Its inclusiveness and comprehensiveness may make it difficult to find a specific answer for a drug information question. However, when comparing or contrasting options within a therapeutic class, this remains the gold standard.
Assessment: For comparing multiple drugs within a therapeutic class, this is the preferred resource; indeed, it is the only one in pharmacy to accomplish this task. It allows users to successfully recommend an agent based on specific patient cases or for appropriate substitution within a class based on adverse effects, copay or formulary considerations.


Consultas y Ventas:                                                                     ventas@novabooks.info
By Telephone:   7218760
By Mobile:          981570582 • 946512957
Nextel:               51*651*2957
Blog:                  http://novabooksinfo.blogspot.com
Facebook:         https://www.facebook.com/Novabooks.info
Skype:               novabooks

Competence Assessment Tools for Health-System Pharmacies, 5th Edition - 2015 - ASPH


Competence Assessment Tools for Health-System Pharmacies, 5th Edition - 2015
Author: Lee B. Murdaugh
Publisher: American Society of Health-System Pharmacists - ASHP
Published: 2015
Hardback, 1 volume
Pages: 700 pp.
Product Dimensions: 28.20 cm x 22.00 cm
ISBN: 9781585284023

Since its original publication, Competence Assessment Tools for Health-System Pharmacies has continued to meet the changing needs of pharmacy directors and their staff. The fifth edition is a necessary addition to every pharmacy’s resources.
Newly updated and expanded, Competence Assessment Tools provides practical tools to assess and document an employee's ability to perform assigned duties and meet the human resource requirements of CMS, The Joint Commission, and other accrediting organizations. Save time and increase efficiency with this essential tool that supplements and reinforces staff knowledge in key competency areas. It features an enhanced companion website that allows you to easily adapt many of the forms included in the book for your own practice including the job descriptions and orientation record. It offers updated resources for customizing job descriptions, including job description, competence assessment summary, and performance evaluation templates for a Pharmacy Purchasing Technician.

This edition has many changes and updates to meet current guidelines and new standards, such as the following:
§  10 new competencies created by subject matter experts
§  A crosswalk guide identifying competencies appropriate for pharmacists and pharmacy technicians
§  Updated competencies on compounding sterile preparations and compounding hazardous drugs to reflect current USP requirements and the addition of study guides
§  Expanded information on the revised Occupational Safety and Health Administration (OSHA) Hazard Communication Standard
§  Updated information about safe injection practices from the Centers for Disease Control and Prevention
§  Updated confidentiality and patients’ rights chapter to reflect current legislation
§  Updated pharmaceutical care competencies to reflect current practice

All-new chapters in the fifth edition include:
§  Aminoglycoside dosing
§  Educating the pharmacy staff
§  Parenteral anticoagulant therapy
§  Oral anticoagulant therapy
§  Medication dosing in hepatic dysfunction
§  Compounding nonsterile preparations
§  Four chapters specific to pharmacy technicians on age-specific competencies

In addition to helping pharmacy directors and staff provide more informed patient care and meet The Joint Commission accreditation standards, the new fifth edition gives you peace of mind that your pharmacy has access to the most up-to-date resources available.




Rules and Guidance for Pharmaceutical Manufacturers Distributors 2015 - The Green Guide


Rules and Guidance for Pharmaceutical Manufacturers Distributors 2015 - The Green Guide
Author: MHRA (Medicines and Healthcare products Regulatory Agency)
Publisher: Pharmaceutical Press
Published: 2015
Hardback, 1 volume
Pages: 232 pp.
Product Dimensions: 244 x 172mm

This is the ninth edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors, compiled by MHRA. Commonly known as the Green Guide, it remains an essential reference for all manufacturers and distributors of medicines in Europe. It provides a single authoritative source of European and UK guidance, information and legislation relating to the manufacture and distribution of human medicines.
The Green Guide reproduces all the elements of the new Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2015 (the Orange Guide) that are relevant to distributors. So if you’re involved in the wholesale supply, distribution and brokering of medicines for human use and the distribution of active substances, this is the one-stop guide you need.

This 2015 edition has been updated to incorporate the revised EU Guidelines on Good Distribution Practice. In addition, it includes new sections on:
§  GDP Quality Systems
§  The Gold Standard for Responsible Persons
§  MHRA Innovation Office
§  The Application and Inspection process – 'what to expect'
§  List of persons who can be supplied with medicines by way of wholesale dealing (Human Medicines Regulations 2012)
§  EU Commission Q&A on GDP guidelines
§  Controls on certain medicinal products
§  Compliance Management and Inspection Action Group
§  Handling returns of non-defective medicinal products
§  Risk-based inspection programme
§  Product recall/withdrawal – testing the recall process
§  Short term storage of ambient and refrigerated medicinal products – requirements for a Wholesale Dealers Authorisation (WDA)

The work also includes a new flow chart on registration requirements for UK companies involved in the sourcing and supply of active substances (ASs) to be used in the manufacture of licensed human medicines.
The Green Guide is compiled by the Inspection, Enforcement and Standards Division, MHRA, London, UK. Building on the restructured contents and fresh design of the last edition, it’s easier than ever to find the answers you need.


Consultas y Ventas:                                                                     ventas@novabooks.info
By Telephone:   7218760
By Mobile:          981570582 • 946512957
Nextel:               51*651*2957
Blog:                  http://novabooksinfo.blogspot.com
Facebook:         https://www.facebook.com/Novabooks.info
Skype:               novabooks

sábado, 28 de febrero de 2015

Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2015 - The Orange Guide


Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2015 - The Orange Guide
Author: MHRA (Medicines and Healthcare products Regulatory Agency)
Publisher: Pharmaceutical Press
Published: 2015
Hardback, 1 volume
Pages: 672 pp.
Product Dimensions: 244 x 172mm

ISBN: 978 0 85711 171 5

This is the ninth edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors, compiled by MHRA. Commonly known as the Orange Guide, it remains an essential reference for all manufacturers and distributors of medicines in Europe. It provides a single authoritative source of European and UK guidance, information and legislation relating to the manufacture and distribution of human medicines.

The new 2015 edition incorporates all the significant updates and additions to the detailed European Community guidelines on GMP since the last edition, including the revised EU Guidelines on Good Distribution Practice.

The Book include: In addition, it contains new sections
§  The Gold Standard for Responsible Persons
§  MHRA Innovation Office
§  The Application and Inspection process for new licences – "what to expect”
§  MHRA Compliance Management and Inspection Action Group
§  MHRA Risk-based inspection programme
§  Naming Contract Quality Control (QC) laboratories
§  GDP Quality Systems
§  A new flow chart on registration requirements for UK companies involved in the sourcing and supply of active substances (ASs), to be used in the manufacture of licensed human medicines
Building on the restructured contents and fresh redesign of the last edition, you’ll find all the answers you need to stay informed.

Contents:
1. MHRA: Licensing, Inspection and Enforcement for Human Medicines
2. EU Guidance on Good Manufacturing Practice

Part I: Basic Requirements for Medicinal Products
1. Pharmaceutical Quality System
2. Personnel
3. Premises and Equipment
4. Documentation
5. Production
6. Quality Control
7. Outsourced Activities
8. Complaints, Quality Defects and Product Recalls
9. Self Inspection
Annex 1. Manufacture of Sterile Medicinal Products
Annex 2. Manufacture of Biological Active Substances and Medicinal Products for Human Use
Annex 3. Manufacture of Radiopharmaceuticals


Annex 4. Manufacture of Veterinary Medicinal Products Other than Immunological Veterinary Medicinal Products
Annex 5. Manufacture of Immunological Veterinary Medicinal Products
Annex 6. Manufacture of Medicinal Gases
Annex 7. Manufacture of Herbal Medicinal Products
Annex 8. Sampling of Starting and Packaging Materials
Annex 9. Manufacture of Liquids, Creams and Ointments
Annex 10. Manufacture of Pressurised Metered Dose Aerosol Preparations for Inhalation
Annex 11. Computerised Systems
Annex 12. Use of Ionizing Radiation in the Manufacture of Medicinal Products
Annex 13. Investigational Medicinal Products
Annex 14. Manufacture of Medicinal Products Derived from Human Blood or Plasma
Annex 15. Qualification and Validation
Annex 16. Certification by a Qualified Person and Batch Release
Annex 17. Parametric Release
Annex 18. Good Manufacturing Practice for Active Pharmaceutical Ingredients
Annex 19. Reference and Retention Samples
Glossary of Terms Used in the EU Guide to GMP

Part II: Basic Requirements for Active Substances Used as Starting Materials

Part III: GMP Related Documents
Site Master File – Explanatory Notes on the Preparation of a Site Master File
Annex Content of Site Master File
Quality Risk Management (ICH Q9)
Annex I. Risk Management Methods and Tools
Annex II. Potential Applications for Quality Risk Management
ICH Q10 Note for Guidance on Pharmaceutical Quality System (ICH Q10)
Annex 1. Potential Opportunities to Enhance Science and Risk Based Regulatory Approaches
Annex 2. MRA Batch Certificate

3. UK Guidance on Manufacture
4. UK Guidance on the Manufacture, Importation and Distribution of Active Substances
5. EU Legislation on Manufacture and Importation
6. UK Legislation on Manufacture and Importation
7. UK Legislation on the Manufacture, Importation and Distribution of Active Substances
8. Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)
9. UK Guidance on Wholesale Distribution Practice
10. UK Guidance on Brokering Medicines
11. EU Legislation on Wholesale Distribution and Brokering Medicines
12. UK Legislation on Wholesale Distribution
13. UK Legislation on Brokering Medicines
Glossary of Legislation
Appendix



Consultas y Ventas:                                                                     ventas@novabooks.info
By Telephone:   7218760
By Mobile:          981570582 • 946512957
Nextel:               51*651*2957
Blog:                  http://novabooksinfo.blogspot.com
Facebook:         https://www.facebook.com/Novabooks.info
Skype:               novabooks



miércoles, 18 de febrero de 2015

Handbook of Pharmaceutical Excipients, 7 edition


Handbook of Pharmaceutical Excipients, 7 edition
Rowe, Raymond C; Sheskey, Paul J; Cook, Walter G; Fenton, Marian E.
Publisher: Pharmaceutical Press
Edition: 7
Published: 2012
Hardback, 1 volume
Pages: 1064 pp.

Product Dimensions: 276 x 219mm.

Uniquely, the Handbook of Pharmaceutical Excipients collects together the essential data on the physical properties of excipients, drug safety and potential drug toxicity. Information is presented in a structured and easy-to-use format.
Written concisely by leading international experts, the Handbook has become the best first drug reference point for users of excipients across many industries.

Proven worth
Since its launch, drug formulators, drug manufacturers, regulatory associations and legal bodies have established it as the go-to reference work on excipients. Pharmacists and chemists have come to rely upon it as the dependable source of pharmaceutical formulation information. In other industries such as food formulation and cosmetics formulation it has proved its worth time and time again.

Improvements to the Handbook of Pharmaceutical Excipients, 7 edition include:
§  This new 7th edition enhances that value and the Handbook of Pharmaceutical Excipients' reputation for excellence and practicality in the laboratory and library.
§  All drug monographs fully updated in the light of current knowledge
§  Important new content including 40 new drug monographs and IR spectra figures
§  New two colour printing to further enhance usability in daily practice
§  Directory of suppliers updated and indexed by country and by monograph, providing quick access to worldwide trade name and supplier information, including the specific grades or types of excipients that are commercially available.

Monographs benefit from a standardized, easy-to-use template and include:
§  pharmacopoeial information from the UK, Europe, Japan and the United States where relevant
§  non-proprietary names and synonyms
§  chemical name, CAS Registry number, empirical formula, molecular weight
§  functional category, applications and incompatibilities
§  material description and typical excipient properties
§  safety, stability, storage and handling information
§  method of drug manufacture
§  related substances
§  primary references
§  editorial comments
§  author details and revision date


domingo, 15 de febrero de 2015

AATCC Technical Manual 2015




AATCC Technical Manual 2015
Author: American Association of Textile Chemists and Colorists (AATCC)

Language: English

AATCC is probably best known for its standardized test methods and evaluation procedures, compiled in the annual AATCC Technical Manual. Each test method is designated by a number followed by a date, which indicates the year in which the method was issued, last revised, or reaffirmed. The designation should be quoted in full in referring to a particular method.

An important feature of all AATCC test methods is that test results are numerically quantified as opposed to being reported as pass-fail. Test results are the basis for describing material or process characteristics that are not in themselves intended to be performance specifications.
AATCC policy prohibits endorsement of such specifications. Buyer and seller, or regulatory bodies, may establish pass-fail specifications based on the results of AATCC test methods. 

















MEYLER'S Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Fifteenth Edition) in 6 Volumens


MEYLER'S Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Fifteenth Edition) in 6 Volumens
Editor:                             J.K. Aronson
Publishers:                    ELSEVIER
Format:                          Hardcover in 6 Volumens
Pages:                           4192 pages
Publication date:         2006
Edition number:          15
Product dimensions:   21.00 cm x 28.50 cm

Country Origin:              Great Britain


Key Features:
* Enhanced encyclopedic format with drug monographs now organized alphabetically
* Completely expanded coverage of each drug - thalidomide warranted three sentences in Meyler's 14th edition, but is now a 13 page extensive monograph
* Clearer, systematic organization of information for easier reading including case histories to provide perspective on each listing
* Extensive bibliography with over 40,000 references - Meyler's 15th edition incorporates all relevant citations from Meyler's 14th, but also includes relevant citations from previous editions of Meyler's and Side Effects of Drugs Annuals to give a historical perspective on the use and safety of drugs


Description:
Building on the success of the 14 previous editions, this remarkable reference has been extensively reorganized and expanded and now comprises almost 1,500 individual drug articles providing the most complete coverage of adverse reactions and interactions found anywhere. Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature making this a must have for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary or pharmaceutical company.

Readership:
Academic and medical libraries, clinical pharmacologists, pharmacists in the pharmaceutical industry, regulatory organizations, and hospital dispensaries

Contents:
§  Contributors
§  Foreword
§  Contents
§  How to use this book
§  Overview of Drug Monographs
§  Preface
§  Drug Monographs
§  Index of Drug Names
§  Index of Adverse Reactions

Meet the Author
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford in ENGLAND and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is also the editor of Meyler's Side Effects of Drugs and the Side Effects of Drugs Annual series. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.